REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abbreviated Unaudited Accounts |
|
For The Year Ended 31 July 2016 |
|
for |
|
ARISE PHARMA LTD |
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abbreviated Unaudited Accounts |
|
For The Year Ended 31 July 2016 |
|
for |
|
ARISE PHARMA LTD |
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
|
|
|
|
|
Contents of the Abbreviated Accounts |
For The Year Ended 31 July 2016 |
|
|
|
|
Page |
|
Company Information | 1 |
|
Abbreviated Balance Sheet | 2 |
|
Notes to the Abbreviated Accounts | 4 |
ARISE PHARMA LTD |
|
Company Information |
For The Year Ended 31 July 2016 |
|
|
|
|
|
|
|
DIRECTORS: |
|
|
|
|
|
|
|
|
SECRETARY: |
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
ACCOUNTANTS: |
|
Accountants & Tax Advisers |
|
|
|
|
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
Abbreviated Balance Sheet |
31 July 2016 |
|
31.7.16 | 31.7.15 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 2 |
|
|
Investments | 3 |
|
|
|
|
|
CURRENT ASSETS |
Debtors |
|
|
Cash at bank |
|
|
|
|
CREDITORS |
Amounts falling due within one year |
|
|
NET CURRENT ASSETS |
|
|
TOTAL ASSETS LESS CURRENT
LIABILITIES |
|
|
|
CREDITORS |
Amounts falling due after more than one
year |
|
|
NET ASSETS |
|
|
|
CAPITAL AND RESERVES |
Called up share capital | 4 |
|
|
Profit and loss account |
|
|
SHAREHOLDERS' FUNDS |
|
|
|
|
|
|
|
The directors acknowledge their responsibilities for: |
(a) |
ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and |
(b) |
preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
Abbreviated Balance Sheet - continued |
31 July 2016 |
|
|
|
|
|
The financial statements were approved by the Board of Directors on
|
|
|
|
|
|
|
|
|
|
|
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
Notes to the Abbreviated Accounts |
For The Year Ended 31 July 2016 |
|
1. | ACCOUNTING POLICIES |
|
Accounting convention |
The financial statements have been prepared under the historical cost convention and in accordance with the |
Financial Reporting Standard for Smaller Entities (effective January 2015). |
|
Turnover |
Turnover represents net invoiced sales of services, excluding value added tax. |
|
Tangible fixed assets |
|
|
Plant and machinery etc | - |
|
|
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance |
sheet date. |
|
2. | TANGIBLE FIXED ASSETS |
Total |
£ |
COST |
At 1 August 2015 |
|
Additions |
|
At 31 July 2016 |
|
DEPRECIATION |
At 1 August 2015 |
|
Charge for year |
|
At 31 July 2016 |
|
NET BOOK VALUE |
At 31 July 2016 |
|
At 31 July 2015 |
|
|
3. | FIXED ASSET INVESTMENTS |
Investments |
other |
than |
loans |
£ |
COST |
At 1 August 2015 |
and 31 July 2016 |
|
NET BOOK VALUE |
At 31 July 2016 |
|
At 31 July 2015 |
|
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
Notes to the Abbreviated Accounts - continued |
For The Year Ended 31 July 2016 |
|
3. | FIXED ASSET INVESTMENTS - continued |
|
The company's investments at the Balance Sheet date in the share capital of companies include the following: |
|
Associated company |
|
The company had an investment at the balance sheet date in the share capital of Ace Laboratories Ltd, company |
incorporated in England. Its principal activity is that of Pharmaceuticals quality controls testing & research. At |
the balance sheet date the company held 110 ordinary shares representing a 22% holding. During the year the |
company made loans to Ace Laboratories Ltd amounting to £60,000. |
Loans |
£ |
At 1 August 2015 |
|
Additions | 60,000 |
At 31 July 2016 | 236,000 |
|
4. | CALLED UP SHARE CAPITAL |
|
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 31.7.16 | 31.7.15 |
value: | £ | £ |
|
Ordinary Share | 1.00 |
|
|